（株）ジェノメンブレン Information

Genomembrane Co., Ltd. was established as a bio-tech venture company in April, 2002, by a group of scientists. GenoMembrane's aims are to provide transporter-related products and services that will be useful in the development and design of novel drugsfor clinical application. With the progress of research on the function of transporters as drug carriers, it has become increasingly important to takeaccount of their effects at an early stage during drug development in order to minimize the costs associated with unsuccessfuldrugs. GenoMembrane also provides or collaboration in the pharmacological evaluation of drug candidates to minimize costs, helpimprove the success rate of candidate drugs, and speed up new drug development.